These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24999757)

  • 1. Clinical significance of serum fibronectin and vitronectin levels in melanoma patients.
    Tas F; Karabulut S; Bilgin E; Tastekin D; Duranyildiz D
    Melanoma Res; 2014 Oct; 24(5):475-9. PubMed ID: 24999757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum caveolin-1 levels in melanoma patients.
    Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D
    Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum claudin-1 levels in melanoma patients.
    Tas F; Bilgin E; Erturk K; Duranyildiz D
    Melanoma Res; 2016 Aug; 26(4):377-81. PubMed ID: 26886788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum M30 and M65 levels in melanoma.
    Tas F; Karabulut S; Serilmez M; Yildiz I; Sen F; Ciftci R; Duranyildiz D
    Melanoma Res; 2013 Oct; 23(5):390-5. PubMed ID: 23812330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of coagulation assays in melanoma.
    Tas F; Ciftci R; Kilic L; Bilgin E; Keskin S; Sen F; Yildiz I; Yasasever V
    Melanoma Res; 2012 Oct; 22(5):368-75. PubMed ID: 22889867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.
    Ortega-Martínez I; Gardeazabal J; Erramuzpe A; Sanchez-Diez A; Cortés J; García-Vázquez MD; Pérez-Yarza G; Izu R; Luís Díaz-Ramón J; de la Fuente IM; Asumendi A; Boyano MD
    Int J Cancer; 2016 Oct; 139(7):1598-607. PubMed ID: 27216146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
    Tas F; Bilgin E; Karabulut S; Duranyildiz D
    Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin predicts the outcome of acute-on-chronic hepatitis B liver failure.
    Chen Y; Shao Z; Yin Z; Jiang Z
    Int Health; 2015 Jan; 7(1):67-72. PubMed ID: 25173344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
    Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of bronchoalveolar lavage vitronectin in hypersensitivity pneumonitis.
    Teschler H; Pohl WR; Thompson AB; Konietzko N; Mosher DF; Costabel U; Rennard SI
    Am Rev Respir Dis; 1993 Feb; 147(2):332-7. PubMed ID: 7679264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patients.
    Egberts F; Momkvist A; Egberts JH; Kaehler KC; Hauschild A
    Anticancer Res; 2010 May; 30(5):1799-805. PubMed ID: 20592382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance and diagnostic value of protein S-100 and tyrosinase in patients with malignant melanoma.
    Andrés R; Mayordomo JI; Visus C; Isla D; Godino J; Escudero P; Saenz A; Ortega E; Lastra R; Lambea J; Aguirre E; Elosegui L; Marcos I; Ruiz-Echarri M; Millastre E; Sáez-Gutierrez B; Asin L; Vidal MJ; Ferrer A; Giner A; Larrad L; Carapeto FJ; Tres A
    Am J Clin Oncol; 2008 Aug; 31(4):335-9. PubMed ID: 18845991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma.
    Deichmann M; Benner A; Waldmann V; Bock M; Jäckel A; Näher H
    J Exp Clin Cancer Res; 2000 Sep; 19(3):301-7. PubMed ID: 11144523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome.
    Tas F; Bilgin E; Karabulut S; Tastekin D; Duranyildiz D
    Mol Clin Oncol; 2016 Apr; 4(4):655-659. PubMed ID: 27073685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value and prognostic significance of plasmatic proteasome level in patients with melanoma.
    Henry L; Lavabre-Bertrand T; Douche T; Uttenweiler-Joseph S; Fabbro-Peray P; Monsarrat B; Martinez J; Meunier L; Stoebner PE
    Exp Dermatol; 2010 Dec; 19(12):1054-9. PubMed ID: 20707810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma.
    Hoejberg L; Bastholt L; Johansen JS; Christensen IJ; Gehl J; Schmidt H
    Melanoma Res; 2012 Aug; 22(4):287-93. PubMed ID: 22617301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancer.
    Tas F; Karabulut S; Serilmez M; Karabulut M; Duranyildiz D
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):127-31. PubMed ID: 26499899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.